Pilot study of an automated method to determine Melasma Area and Severity Index

Summary Background Objective outcome measures for melasma severity are essential for the evaluation of severity as well as results of treatment. The modified Melasma Area and Severity Index (mMASI) score is a validated tool for assessing melasma severity but is often subject to inter‐observer variab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2015-06, Vol.172 (6), p.1535-1540
Hauptverfasser: Tay, E.Y., Gan, E.Y., Tan, V.W.D., Lin, Z., Liang, Y., Lin, F., Wee, S., Thng, T.G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background Objective outcome measures for melasma severity are essential for the evaluation of severity as well as results of treatment. The modified Melasma Area and Severity Index (mMASI) score is a validated tool for assessing melasma severity but is often subject to inter‐observer variability. Objectives To develop and validate a novel image analysis software designed to automatically calculate the area and degree of hyperpigmentation in melasma from computer image analysis of whole‐face digital photographs, thereby deriving an automated mMASI score (aMASI). Methods The algorithm was developed in collaboration between dermatologists and image analysis experts. Firstly, using an adaptive threshold method, the algorithm identifies, segments and calculates the areas involved. It then calculates the darkness. Finally, the derived area and darkness are then used to calculate mMASI. The scores derived from the algorithm are validated prospectively. Twenty‐nine patients with melasma using depigmenting agents were recruited for validation. Three dermatologists scored mMASI at baseline and post‐treatment using standardized photographs. These scores were compared with aMASI scores derived from computer analysis. Results aMASI scores correlated well with clinical mMASI pre‐treatment (r = 0·735, P 
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.13699